Cellular responses to excess phospholipid
- PMID: 10092620
- DOI: 10.1074/jbc.274.14.9400
Cellular responses to excess phospholipid
Abstract
Phosphatidylcholine (PtdCho) is the major membrane phospholipid in mammalian cells, and its synthesis is controlled by the activity of CDP:phosphocholine cytidylyltransferase (CCT). Enforced CCT expression accelerated the rate of PtdCho synthesis. However, the amount of cellular PtdCho did not increase as a result of the turnover of both the choline and glycerol components of PtdCho. Metabolic labeling experiments demonstrated that cells compensated for elevated CCT activity by the degradation of PtdCho to glycerophosphocholine (GPC). Phospholipase D-mediated PtdCho hydrolysis and phosphocholine formation were unaffected. Most of the GPC produced in response to excess phospholipid production was secreted into the medium. Cells also degraded the excess membrane PtdCho to GPC when phospholipid formation was increased by exposure to exogenous lysophosphatidylcholine or lysophosphatidylethanolamine. The replacement of the acyl moiety at the 1-position of PtdCho with a non-hydrolyzable alkyl moiety prevented degradation to GPC. Accumulation of alkylacyl-PtdCho was associated with the inhibition of cell proliferation, demonstrating that alternative pathways of degradation will not substitute. GPC formation was blocked by bromoenol lactone, implicating the calcium-independent phospholipase A2 as a key participant in the response to excess phospholipid. Owing to the fact that PtdCho is biosynthetically converted to PtdEtn, excess PtdCho resulted in overproduction and exit of GPE as well as GPC. Thus, general membrane phospholipid homeostasis is achieved by a balance between the opposing activities of CCT and phospholipase A2.
Similar articles
-
CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke.J Biol Chem. 2006 Mar 10;281(10):6718-25. doi: 10.1074/jbc.M512112200. Epub 2005 Dec 27. J Biol Chem. 2006. Retraction in: J Biol Chem. 2013 Mar 15;288(11):7549. doi: 10.1074/jbc.A113.512112. PMID: 16380371 Retracted.
-
Regulation of phosphatidylcholine homeostasis by calcium-independent phospholipase A2.Biochim Biophys Acta. 1999 Jul 9;1439(1):77-88. doi: 10.1016/s1388-1981(99)00078-5. Biochim Biophys Acta. 1999. PMID: 10395967
-
Contribution of lipid second messengers to the regulation of phosphatidylcholine synthesis during cell cycle re-entry.Biochim Biophys Acta. 2004 Nov 8;1686(1-2):85-99. doi: 10.1016/j.bbalip.2004.09.001. Biochim Biophys Acta. 2004. PMID: 15522825
-
Phosphatidylcholine and the CDP-choline cycle.Biochim Biophys Acta. 2013 Mar;1831(3):523-32. doi: 10.1016/j.bbalip.2012.09.009. Epub 2012 Sep 23. Biochim Biophys Acta. 2013. PMID: 23010477 Free PMC article. Review.
-
Phosphatidylcholine synthesis and its catabolism by yeast neuropathy target esterase 1.Biochim Biophys Acta. 2007 Mar;1771(3):331-6. doi: 10.1016/j.bbalip.2006.04.004. Epub 2006 May 12. Biochim Biophys Acta. 2007. PMID: 16731034 Review.
Cited by
-
Substrate efflux propensity is the key determinant of Ca2+-independent phospholipase A-β (iPLAβ)-mediated glycerophospholipid hydrolysis.J Biol Chem. 2015 Apr 17;290(16):10093-103. doi: 10.1074/jbc.M115.642835. Epub 2015 Feb 23. J Biol Chem. 2015. PMID: 25713085 Free PMC article.
-
Effect of over-expression of neuropathy target esterase on mammalian cell proliferation.Cell Prolif. 2006 Oct;39(5):429-40. doi: 10.1111/j.1365-2184.2006.00399.x. Cell Prolif. 2006. PMID: 16987144 Free PMC article.
-
Marine phospholipids--a promising new dietary approach to tumor-associated weight loss.Support Care Cancer. 2010 Feb;18(2):159-70. doi: 10.1007/s00520-009-0640-4. Epub 2009 Apr 29. Support Care Cancer. 2010. PMID: 19404684 Clinical Trial.
-
Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T.Bipolar Disord. 2010 Dec;12(8):825-33. doi: 10.1111/j.1399-5618.2010.00884.x. Bipolar Disord. 2010. PMID: 21176029 Free PMC article. Clinical Trial.
-
Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.PLoS One. 2016 Aug 25;11(8):e0161803. doi: 10.1371/journal.pone.0161803. eCollection 2016. PLoS One. 2016. PMID: 27560924 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources